Article
Severe asthma and personalized approach in the choice of biologic.
Current opinion in allergy and clinical immunology - 1 Aug 2022
Di Bona Danilo, Spataro Federico, Carlucci Palma, Paoletti Giovanni, Canonica Giorgio W
Abstract excerpt
PURPOSE OF REVIEW: Severe asthma requires intensive pharmacological treatment to achieve disease control. Oral corticosteroids are effective, but their use is burdened with important side effects. Biologics targeting the specific inflammatory pathways underpinning the disease have been shown to be effective but not all patients respond equally well. As we treat more patients than those who can respond, our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.